研究报告 |
|
|
|
|
基于重组毕赤酵母的fusaruside生物合成 * |
田园(),李艳玲 |
山东第一医科大学(山东省医学科学院)生命科学学院 泰安 271016 |
|
Biosynthesis of Fusaruside Based on Recombinant Pichia pastoris |
Yuan TIAN(),Yan-ling LI |
College of Life Science, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian 271016, China |
[1] |
刘莹, 王玉斌, 张琪 , 等. 新型小分子免疫抑制剂研究进展. 中国新药杂志, 2011,20(20):1981-1988.
|
|
Liu Y, Wang Y B, Zhang Q , et al. Development in small molecule immunosuppressive drugs. China J New Drugs, 2011,20(20):1981-1988.
|
[2] |
O’Shea J J, Pesu M, Borie D C , et al. A new modality for immunosuppression:targeting the JAK/STAT pathway. Nat Rev Drug Discov, 2004,3(7):555-564.
|
[3] |
Wu X F, Wu X X, Guo W J , et al. Cerebroside D,a glycoceramide compound, improves experimental colitis in mice with multiple targets against activated T lymphocytes. Toxicol Appl Pharm, 2012,263(3):296-302.
doi: 10.1016/j.taap.2012.07.001
|
[4] |
Wu X X, Sun Y, Guo W J , et al. Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside,a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice. Biochem Pharmacol, 2012,84(9):1164-1173.
doi: 10.1016/j.bcp.2012.08.006
|
[5] |
Li J, Ferris R L . PD-1/SHP-2 negatively regulate Tc1/Th1 phenotypic responses and activation of T cells in the tumor microenvironment. J Immunother Cancer, 2014,2(S3):221.
|
[6] |
Wu X X, Guo W J, Wu L M . et al. Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis. J Immunol, 2012,189(7):3497-3507.
doi: 10.4049/jimmunol.1201006
|
[7] |
Shu R G, Wang F W, Yang Y M , et al. Antibacterial and xanthine oxidase inhibitory cerebrosides from Fusarium sp.IF-121,an endophytic fungus in Quercus variabilis. Lipids, 2004,39(7):667-673.
doi: 10.1007/s11745-004-1280-9
|
[8] |
Black F J, Kocienski P . Synthesis of phalluside-1 and Sch II using 1,2-metallate rearrangements. Org Biomol Chem, 2010,8(5):1188-1193.
doi: 10.1039/b920285d
|
[9] |
Ro D K, Paradise E M, Ouellet M , et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature, 2006,440(7086):940-943.
|
[10] |
Farhi M, Marhevka E, Ben-Ari J , et al. Generation of thepotent anti-malarial drug artemisinin in tobacco. Nat Biotechnol, 2011,29(12):1072-1074.
|
[11] |
Ternes P, Wobbe T, Schwarz M , et al. Two pathways of sphingolipid biosynthesis are separated in the yeast Pichia pastoris. J Biol Chem, 2011,286(13):11401-11414.
doi: 10.1074/jbc.M110.193094
|
[12] |
Tian Y, Zhao G Y, Fang W , et al. Δ10(E)-Sphingolipid desaturase involved in fusaruside mycosynthesis and stress adaptation in Fusarium graminearum. Sci Rep, 2015,5:10486.
|
[13] |
Zaüner S, Zahringer U, Lindner B , et al. Identification and functional characterization of the 2-hydroxy fatty N-acyl-Delta3(E)-desaturase from Fusarium graminearum. J Biol Chem, 2008,283(52):36734-36742.
doi: 10.1074/jbc.M807264200
|
[14] |
张欢, 黄思超, 蔡绍晖 . 基于2A肽策略构建多基因表达载体的研究进展. 中国生物工程杂志, 2013,33(1):104-108.
|
|
Zhang H, Huang S C, Cai S H . Development of 2A peptide-based strategies for constructing multicistronic expression vectors. China Biotechnology, 2013,33(1):104-108.
|
[15] |
Brazier-Hicks M, Edwards R . Metabolic engineering of the flavone-C-glycoside pathway using poly protein technology. Metab Eng, 2013,16:11-20.
doi: 10.1016/j.ymben.2012.11.004
|
[16] |
Beekwilder J, van Rossum H M, Koopman F , et al. Polycistronic expression of a β-carotene biosynthetic pathway in Saccharomyces cerevisiae coupled to β-ionone production. J Biotechno, 2014,192(Part B):383-392.
doi: 10.1016/j.jbiotec.2013.12.016
|
[17] |
Geier M, Fauland P, Vogl T , et al. Compact multi-enzyme pathways in P.pastoris. Chem Commun, 2015,51(9):1643-1646.
doi: 10.1039/C4CC08502G
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|